CROs Shift from Hired Hands to Trusted Partners
CROs Shift from Hired Hands to Trusted Partners CROs Shift from Hired Hands to Trusted Partners With the advent of novel therapies, such as advanced cell and gene therapies, and the rise of global threats, such as viral pandemics and antibiotic-resistant bacteria, conventional approaches to drug and vaccine development are beginning to show signs of strain. Innovative approaches may require intensive collaboration among regulators, developers, manufacturers, and contract research organizations. seksan [Mongkhonkhamsao/Getty Images] CROs Shift from Hired Hands to Trusted Partners Sponsors pa...
Source: genengnews.com